Background: Current lung adenocarcinoma pathological classification, published in 2004 by the World Health Organisation, has limited clinical utility. A new multidisciplinary classification has been proposed by the European Respiratory Society, the American Thoracic Society and the International Association for the Study of Lung Cancer; its validation thus far is limited. This project investigated the correlation between lung adenocarcinoma subtype and patient survival.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2011 Published by Elsevier Inc.